A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer

International Journal of Hyperthermia

Volumn 30, Issue 3, 2014, Pages 166-170

  Sousa, Alejandro ^a   Inman, Brant A ^b   Piñeiro, Idelfonso ^a   Monserrat, Victor ^a   Pérez, Alberto ^a   Aparici, Vincente ^a   Gómez, Isabel ^a   Neira, Pilar ^a   Uribarri, Carlos ^a  

^a Hospital Comarcal de Monforte   (Spain)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Bladder cancer; Hyperthermia; Intravesical therapy; Mitomycin C; Neoadjuvant

Indexed keywords

MITOMYCIN; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLADDER CALCIFICATION; BLADDER CAPACITY; BLADDER DISEASE; BLADDER IRRITATION; BLADDER SPASM; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CHEMICAL CYSTITIS; CLINICAL ARTICLE; DRUG DELIVERY DEVICE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEMATURIA; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PAIN; PELVIC DISEASE; PILOT STUDY; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; URINARY TRACT INFECTION; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; PATHOLOGY; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; PILOT PROJECTS; URINARY BLADDER NEOPLASMS;

EID: 84899724880     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2014.900194     Document Type: Article

References (34)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Sylvester RJ, Van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-75.
3. Colombo R, Da Pozzo LF, Lev A, Freschi M, Gallus G, Rigatti P. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 1996;155:1227-32.
4. Herr HW. Role of re-resection in non-muscle-invasive bladder cancer. Scientific World J. 2011;11:283-8.
5. Sfakianos JP, Kim PH, Hakimi AA, Herr HW. The effect of restaging transurethral resection on recurrence and progression rates in patients with non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin. J Urol 2013; 191:341-5.
6. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Impact of routine second transurethral resection on the long-Term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: A prospective randomised clinical trial. Eur Urol 2010; 58:185-90.
7. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005;174:2134-7.
8. Colombo R, Da Pozzo LF, Lev A, Salonia A, Rigatti P, Leib Z, et al. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 1998;159:783-7.
9. Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of nonmuscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60:81-93.
10. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997-1008.
11. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: The what, why and how. BMC Med Res Methodol 2010;10:1-6.
12. BuschW. Einflub von Erysipel. Berliner Klin Wschr 1866;3:245-6.
13. Coley WB. The treatment of malignant tumours by repeated inoculations of Erysipelas, with a report of ten original cases. Am J Med Sci 1893;105:487-511.
14. Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967;20: 1351-81.
15. Suzuki K. Application of heat to cancer chemotherapy-Experimental studies. Nagoya J Med Sci 1967;30:1-21.
16. Vermel EM, Kuznetsova IB. Hyperthermia in the treatment of malignant disease. Probl Oncol 1970;16:96-102.
17. Oliveira TR, Stauffer P, Lee C-T, Landon C, Etienne W, Ashcraft K, et al. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study. Int J Hyperthermia 2013;29:835-44.
18. Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for nonmuscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171-5.
19. Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: An update. Int J Hyperthermia 2011;27:320-43.
20. Muckle DS, Dickson JA. Hyperthermia (42-C) as an adjuvant to radiotherapy and chemotherapy in the treatment of allogeneic VX2 carcinoma in the rabbit. Br J Cancer 1973;27:307-15.
21. Nemoto R, Kato T, Mori H, Iwata K, Harada M. Hyperthermic irrigation of urinary bladder tumour in rabbits. Tohoku J Exp Med 1982;137:199-205.
22. Owusu R, Abern M, Inman B. Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer. Biomed Res Int 2013;2013:262313. doi 10.1155/2013/262313.
23. Van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002;13:1173-84.
24. Calderwood SK, Theriault JR, Gong J. How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia 2005;21:713-16.
25. Rylander MN, Feng Y, Bass J, Diller KR. Thermally induced injury and heat-shock protein expression in cells and tissues. Ann NY Acad Sci 2005;1066:222-42.
26. Frey B, Weiss EM, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012;28:528-42.
27. Ahmed K, Zaidi SF. Treating cancer with heat: Hyperthermia as promising strategy to enhance apoptosis. J Pak Med Assoc 2013;63: 504-8.
28. Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field. Int J Hyperthermia 2006;22:191-6.
29. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43:33-56.
30. Paroni R, Salonia A, Lev A, Da Pozzo LF, Cighetti G, Montorsi G, et al. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 2001;52:273-8.
31. Van der Heijden A, Verhaegh G, Jannsen C, Schalken JA, Witjes JA. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: An in vitro study. J Urol 2005;173:1375-80.
32. Colombo R. Combined treatment with local thermo-chemotherapy for non muscle invasive bladder cancer. The present role in the light of acquired data and preliminary cumulative clinical experiences. Arch Ital Urol Androl 2008;80:149-56.
33. Cordeiro E, Geijsen E, Zum Vorde Sive P, Schooneveltdt G, Sijbrands J, Hulschof M, et al. Novel multi-sensor probe for monitoring bladder temperature during loco-regional chemohyperthermia for non-muscle invasive bladder cancer: Technical feasibility study. J Endourol 2013;27:1504-9.
34. Rath-Wolfson L, Moskovitz B, Dekel Y, Kugel V, Koren R. Combined intravesical hyperthermia and mitomycin chemotherapy: A preliminary in vivo study. Int J Exp Pathol 2003;84:145-52.